You are here

  • Home
  • Archive
  • Volume 82, Issue 5
  • Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers

Article info

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers

Authors

  • Pedro M Machado Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London, UK National Institute for Health Research (NIHR) Biomedical Research Centre (BRC), University College London Hospitals (UCLH) NHS Foundation Trust, London, UK Department of Rheumatology, Northwick Park Hospital, London North West University Healthcare NHS Trust, London, UK PubMed articlesGoogle scholar articles
  • Martin Schäfer Epidemiology and Health Care Research, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany PubMed articlesGoogle scholar articles
  • Anja Strangfeld Epidemiology and Health Care Research, German Rheumatism Research Center (DRFZ Berlin), Berlin, Germany PubMed articlesGoogle scholar articles
  • Laure Gossec Institut Pierre Louis d'Epidémiologie et de Santé Publique, INSERM, Sorbonne Universite, Paris, France Department of Rheumatology, Pitié-Salpêtrière Hospital, AP-HP.Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Milena Gianfrancesco Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  • Saskia Lawson-Tovey Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UK National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK PubMed articlesGoogle scholar articles
  • Elsa F Mateus Standing Committee of People with Arthritis/Rheumatism in Europe (PARE), European Alliance of Associations for Rheumatology (EULAR), Kilchberg, Switzerland Portuguese League Against Rheumatic Diseases (LPCDR), Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Loreto Carmona Instituto de Salud Musculoesquelética, Madrid, Spain PubMed articlesGoogle scholar articles
  • Kimme L Hyrich Centre for Genetics and Genomics Versus Arthritis, The University of Manchester, Manchester, UK National Institute of Health Research Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, UK PubMed articlesGoogle scholar articles
  • Philip C Robinson Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia Royal Brisbane & Women’s Hospital, Metro North Hospital & Health Service, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Jinoos Yazdany Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Pedro M Machado, Centre for Rheumatology and Department of Neuromuscular Diseases, University College London, London WC1E 6JF, UK; p.machado{at}ucl.ac.uk
View Full Text

Citation

Machado PM, Schäfer M, Strangfeld A, et al
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers
Annals of the Rheumatic Diseases 2023;82:e114.

Publication history

  • Received February 9, 2021
  • Accepted February 11, 2021
  • First published February 18, 2021.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage